Is AI pharmaceutical manufacturing really a new dawn for pharmaceutical research and development? | Quantum Bit · Collider x InSilicon Intelligence

Quantum Bit Intelligence Library from Aofei Temple
Quantum Bit | Public Account QbitAI

There is a famous double ten law that has become a headache for new drug development.

On average, each new drug takes more than ten years and one billion dollars to develop, and the R&D efficiency is quite low.

Not only that, now that the low-hanging fruits have almost been picked, how to achieve innovation in drug research and development has also become a major difficulty in the industry.

Now, AI pharmaceutical manufacturing has created a new possibility.

Since the beginning of 2020, the number and financing amount of AI pharmaceutical startups have continued to rise, and representative companies Schrodinger and Relay Therapeutics have already gone public. At the same time, new targets, new compound molecules, and even new drugs are emerging at an accelerated pace.

So, how does AI improve the traditional precision pharmaceutical industry? What problems will arise from the integration of the two? Where will AI pharmaceuticals go in the future?

On the evening of February 24th from 19:00 to 20:00, "Collision Party" invited the leading domestic AI pharmaceutical company, Insilico Medicine , to share with us the founder and CEO Alex Zhavoronkov and CSO and head of drug development, Dr. Ren Feng.

Friends who are interested in AI pharmaceuticals and biotechnology can scan the QR code or click the Book Now button below to book a live broadcast and receive WeChat notifications.

About Insilicon Valley:

Insilico Medicine is an end-to-end artificial intelligence (AI)-driven drug discovery and development company. Through the next-generation AI system, it connects generative biology, generative chemistry and clinical trial analysis. It uses modern machine learning technologies such as deep generative models, reinforcement learning and pre-trained models to build a powerful and efficient AI drug discovery and development platform to identify new targets and generate candidate drugs with molecular structures with specific properties.

One more thing:

In the field of AI pharmaceuticals, the think tank will also release in-depth reports and golden quote videos. Welcome to scan the QR code to add the assistant and enter the vertical community:

If you are deeply involved in the field of AI pharmaceuticals or life sciences, please scan the QR code to add an analyst for in-depth discussion and communication:

About QuantumBit Think Tank:

Quantum位's technology innovation industry connection platform is committed to providing systematic research in the fields of cutting-edge science and technology innovation (such as cutting-edge AI & computers, life sciences, quantum technology and new semiconductors, etc.). Through media, communities and offline activities, based on special technical reports and reports, special exchanges and other forms, it helps decision makers grasp the direction of innovation earlier.

About the Collision Party:

A high-end roundtable column under the Quantum位 Think Tank.

The Collision Party is committed to inviting professionals in the cutting-edge technology field, such as CEOs and CTOs of startups, senior scientists, professional investors, etc., to conduct in-depth discussions and interpretations of specific trends, helping readers to more accurately grasp future technological trends from an industry and professional perspective.

Finally, remember to click "Appointment" to watch the live broadcast~